Neurogenic bowel dysfunction score in spinal cord-injured patients: translation and validation of the Dutch-language NBD score.
Journal
Spinal cord
ISSN: 1476-5624
Titre abrégé: Spinal Cord
Pays: England
ID NLM: 9609749
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
04
02
2021
accepted:
25
06
2021
revised:
25
06
2021
pubmed:
6
8
2021
medline:
25
3
2022
entrez:
5
8
2021
Statut:
ppublish
Résumé
This is a prospective validation study. The neurogenic bowel dysfunction (NBD) score is a widely used symptom-based questionnaire evaluating bowel dysfunction and its impact on quality of life (QoL) in spinal cord-injured patients. This study aimed to translate and validate a Dutch-language NBD score in patients with SCI. Patients with SCI visiting the urology department or general practitioner (GP) in Rotterdam, the Netherlands. Standardized guidelines were followed for the translation and validation process of the NBD score. Adult patients with SCI visiting our urology department were asked to participate by filling in a set of questionnaires: the NBD score, the Fecal Incontinence Quality of Life scale (FIQL), the Fecal Incontinence Severity Index (FISI), and the European Quality of life 5-Dimension 3-Level questionnaire (EQ-5D-3L) at baseline and 1-2 weeks afterward. A control group recruited at a GP office completed the questionnaires once. The following measurement properties were evaluated: content validity, internal consistency, reproducibility, criterion-, and construct validity. Fifty-eight patients and 50 references were included. Content validity was adequate, internal consistency was moderate (Cronbach's alpha 0.56 and 0.30) and reproducibility was adequate (ICC 0.87). Criterion validity was confirmed; NBD score correlated significantly with the FIQL, FISI, and EQ-5D-3L. NBD scores in the patient group were significantly higher than in references, demonstrating good construct validity. The Dutch-language version of the NBD score showed moderate to good measurement properties, and therefore is a reliable tool to measure bowel dysfunction in patients with SCI. We recommend standardized usage of this questionnaire for clinical evaluation and research purposes.
Identifiants
pubmed: 34349233
doi: 10.1038/s41393-021-00668-8
pii: 10.1038/s41393-021-00668-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
223-227Informations de copyright
© 2021. The Author(s), under exclusive licence to International Spinal Cord Society.
Références
Krogh K, Christensen P, Laurberg S. Colorectal symptoms in patients with neurological diseases. Acta Neurol Scand. 2001;103:335–43.
doi: 10.1034/j.1600-0404.2001.103006335.x
Sun WM, MacDonagh R, Forster D, Thomas DG, Smallwood R, Read NW. Anorectal function in patients with complete spinal transection before and after sacral posterior rhizotomy. Gastroenterology. 1995;108:990–8.
doi: 10.1016/0016-5085(95)90194-9
Krogh K, Christensen P. Neurogenic colorectal and pelvic floor dysfunction. Best Pr Res Clin Gastroenterol. 2009;23:531–43.
doi: 10.1016/j.bpg.2009.04.012
Krogh K, Christensen P, Sabroe S, Laurberg S. Neurogenic bowel dysfunction score. Spinal Cord. 2006;44:625–31.
doi: 10.1038/sj.sc.3101887
Coloplast. Coloplast - test your bowel symptoms: coloplast. 2020. https://www.coloplast.us/Global/US/Continence/Peristeen/NBD%20Score.pdf .
Rockwood TH, Church JM, Fleshman JW, Kane RL, Mavrantonis C, Thorson AG, et al. Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum. 2000;43:9–16. discussion -7
doi: 10.1007/BF02237236
t Hoen LA, Utomo E, Schouten WR, Blok BF, Korfage IJ. The fecal incontinence quality of life scale (FIQL) and fecal incontinence severity index (FISI): validation of the Dutch versions. Neurourol Urodyn. 2017;36:710–5.
doi: 10.1002/nau.23003
Rockwood TH, Church JM, Fleshman JW, Kane RL, Mavrantonis C, Thorson AG, et al. Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index. Dis Colon Rectum. 1999;42:1525–32.
doi: 10.1007/BF02236199
Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46:1417–32.
doi: 10.1016/0895-4356(93)90142-N
Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.
doi: 10.1016/j.jclinepi.2006.03.012
de Vet HC, Terwee CB, Knol DL, Bouter LM. When to use agreement versus reliability measures. J Clin Epidemiol. 2006;59:1033–9.
doi: 10.1016/j.jclinepi.2005.10.015
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10.
doi: 10.1016/S0140-6736(86)90837-8
van Doorn T, Groenendijk IM, Scheepe JR, Blok BFM. The neurogenic bowel dysfunction score in patients with multiple sclerosis: validation of the Dutch-language version. (Under Review).
Erdem D, Hava D, Keskinoglu P, Bircan C, Peker O, Krogh K, et al. Reliability, validity and sensitivity to change of neurogenic bowel dysfunction score in patients with spinal cord injury. Spinal Cord. 2017;55:1084–7.
doi: 10.1038/sc.2017.82
de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: a practical guide. Cambridge University Press; 2011.
Reuvers SHM, Korfage IJ, Scheepe JR, Blok BFM. The urinary-specific quality of life of multiple sclerosis patients: Dutch translation and validation of the SF-Qualiveen. Neurourol Urodyn. 2017;36:1629–35.
doi: 10.1002/nau.23168
Noordhoff TC, Scheepe JR, t Hoen LA, Sluis TAR, Blok BFM. The Multiple Sclerosis Intimacy and Sexuality Questionnaire (MSISQ-15): validation of the Dutch version in patients with multiple sclerosis and spinal cord injury. Neurourol Urodyn. 2018;37:2867–74.
doi: 10.1002/nau.23804